Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study

Joo-Ho LEE; Eui-Kyu CHIE; Seung-Yong JEONG; Tae-You KIM; Dae-Yong KIM; Tae-Hyun KIM; Sun-Young KIM; Ji-Yeon BAEK; Hee-Jin CHANG; Min-Ju KIM; Sung-Chan PARK; Jae-Hwan OH; Sung-Hwan KIM; Jong-Hoon LEE; Doo-Ho CHOI; Hee-Chul PARK; Sung-Bum KANG; Jae-Sung KIM.
Cancer Research and Treatment ; : 506-517, 2018.
Artículo en Inglés | WPRIM | ID: wpr-714222

Documentos relacionados

  1. Clinical Implication of Perineural and Lymphovascular Invasion in Rectal Cancer Patients Who Underwent Surgery After Preoperative Chemoradiotherapy.
  2. Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial.
  3. Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
  4. Benefits and disadvantages of preoperative chemoradiotherapy for rectal cancer.
  5. Acute and Chronic Complications After Treatment of Locoregional Anal Cancer: Prevention and Management Strategies.
  6. Prognosis of Concurrent Versus Sequential Chemo-Radiotherapy Induction Followed by Surgical Resection in Patients with Advanced Thymic Epithelial Tumors: A Retrospective Study.
  7. Downstaging after preoperative chemoradiation for locally advanced rectal cancer is associated with better survival than pathologic stage 0-1 disease treated with upfront surgery.
  8. [Comparison of preoperative chemotherapy with concurrent chemoradiotherapy combined with TME for 305 patients with locally advanced rectal cancer].
  9. Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial.
  10. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.